News | July 28, 2021
Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.
The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021
2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy's
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
